Finance

Lists
301331:SHE
Enwei Pharmaceutical Co Ltd
CNÂ¥20.27
-0.34%
(-0.070) 1D
Sep 17, 10:49:25 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
CNÂ¥20.25
High
CNÂ¥20.42
Low
CNÂ¥20.13
Mkt. cap
2.08B
Avg. vol.
1.57M
Volume
458.70K
Dividend
5.08%
Quarterly dividend
CNÂ¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
73.85
52-wk high
CNÂ¥35.60
52-wk low
CNÂ¥18.87
EPS
CNÂ¥0.27
Shares outstanding
102.89M
No. of employees
2K
Open
CNÂ¥20.25
High
CNÂ¥20.42
Low
CNÂ¥20.13
Mkt. cap
2.08B
Avg. vol.
1.57M
Volume
458.70K
Dividend
5.08%
Quarterly dividend
CNÂ¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
73.85
52-wk high
CNÂ¥35.60
52-wk low
CNÂ¥18.87
EPS
CNÂ¥0.27
Shares outstanding
102.89M
No. of employees
2K
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1.5K
Founded1986
Headquarters-
SectorPharmaceutical industry
Websiteenwei.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
187.63M
263.92M
175.33M
199.25M
Cost of goods sold
102.65M
123.62M
77.69M
105.17M
Cost of revenue
102.65M
123.62M
77.69M
105.17M
Research and development expenses
1.76M
1.22M
1.11M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.00M
108.50M
82.73M
90.62M
Operating expense
93.18M
115.42M
85.17M
93.16M
Total operating expenses
195.83M
239.04M
162.86M
198.32M
Operating income
-8.20M
24.87M
12.47M
926.22K
Other non operating income
341.20K
-843.50K
-62.65K
2.71M
EBT including unusual items
-2.54M
20.98M
13.88M
4.07M
EBT excluding unusual items
-6.27M
25.60M
13.52M
4.46M
Income tax expense
-782.36K
5.62M
1.38M
553.50K
Effective tax rate
30.78%
26.77%
9.93%
13.59%
Other operating expenses
2.36M
3.57M
1.89M
706.64K
Net income
-1.76M
15.36M
12.50M
3.52M
Net profit margin
-0.94%
5.82%
7.13%
1.77%
Earnings per share
-
-
-
-
Interest and investment income
2.19M
1.88M
1.69M
816.59K
Interest expense
-606.94K
-308.97K
-578.12K
-
Net interest expenses
1.59M
1.57M
1.11M
816.59K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.02M
36.41M
24.01M
12.87M
Gain or loss from assets sale
-263.27K
138.01K
-
-2.69M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps